The Directorate General of Drug Administration (DGDA) has issued emergency use authorisation (EUA) to Johnson & Johnson's Janssen COVID-19 vaccine in the country.  

With this, a total of six vaccines got approval in Bangladesh for emergency use.

A press notification signed by DGDA Director General Major General Md Mahbubur Rahman on Tuesday revealed the approval of the Johnson & Johnson's Janssen COVID-19 vaccine produced by Belgium.

According to the Johnson & Johnson, the COVID-19 single-dose vaccine is compatible with standard vaccine storage and distribution channels with ease of delivery to remote areas. 

The vaccine is estimated to remain stable for two years at -4°F (-20°C), and a maximum of three months at routine refrigeration at temperatures of 36-46°F (2 to 8°C). 

BDST: 1853 HRS, JUN 15, 2021
SMS